Recognition of Gram-negative bacteria and endotoxin by the innate immune system

Current Opinion in Immunology

Volumn 11, Issue 1, 1999, Pages 19-22

  Ulevitch, Richard J ^a   Tobias, Peter S ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; ENDOTOXIN;

ANTIGEN RECOGNITION; BACTERIAL IMMUNITY; BONE MARROW CELL; GRAM NEGATIVE BACTERIUM; IMMUNE SYSTEM; REVIEW;

EID: 0032997542     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)80004-1     Document Type: Review

References (37)

1. Thomas L The Lives of a Cell. Notes of a Biology Watcher. 1974;The Viking Press, New York.
2. Rietschel ET, Brade H, Holst O, Brade L, Muller-Loennies S, Mamat U, Zahringer U, Beckmann F, Seydel U, Brandenburg Ket al. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Rietschel ET, Wagner H Current Topics in Microbiology and Immunology. 1996;39-81 Springer-Verlag, Berlin.
3. Tobias P, Soldau K, Ulevitch R Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med. 164:1986;777-793.
4. Wright SD, Tobias PS, Ulevitch RJ, Ramos RA Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med. 170:1989;1231-1241.
5. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ Structure and function of lipopolysaccharide binding protein. Science. 249:1990;1429-1433.
6. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC CD14 serves as the cellular receptor for complexes of lipopolysaccharide with lipopolysaccharide binding protein. Science. 249:1990;1431-1433.
7. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:1997;394-397. This paper describes the cloning and some characteristics of the first human toll-like receptor. A link between the innate immune system of Drosophila and man is provided by the data of this report; signalling from the cell surface to the nucleus is shown to be a property of this receptor.
8. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF A family of human receptors structurally related to Drosophila toll. Proc Natl Acad Sci USA. 95:1998;588-593. A description of a family of human Toll-like receptors is presented in this report. The first hint that Toll-like-receptor 4 might be related to LPS responses can be inferred from this paper because of the chromosomal localization of human Toll-like-receptor 4 (on chromosome 9), corresponding to a region of mouse chromosome 4 near to the location of the Lps gene.
9. Gray PW, Flaggs G, Leong SR, Gumina RJ, Weiss J, Ooi CE, Elsbach P Cloning of the cDNA of a human neutrophil bactericidal protein. Structure and functional correlations. J Biol Chem. 264:1989;9505-9509.
10. Day JR, Albers JJ, Lofton-Day CE, Gilbert TL, Ching AFT, Grant FJ, O'Hara PJ, Marcovina SM, Adolphson JL Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. J Biol Chem. 269:1994;9388-9391.
11. Jiang X-C, Bruce C, Cocke T, Wang S, Boguski M, Tall AR Point mutagenesis of positively charged amino acids of cholesteryl ester transfer protein: conserved residues within the lipid transfer/lipopolysaccharide binding protein gene family essential for function. Biochemistry. 34:1995;7258-7263.
12. Ulevitch RJ Recognition of bacterial endotoxins by receptor-dependent mechanisms. Adv Immunol. 53:1993;267-289.
13. Poltorak A, He X, Smirnova I, Liu M-Y, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos Cet al. Defective LPS signalling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088. Here, positional cloning demonstrates that the Lps gene is homologous to human Toll-like-receptor 4. The mutation responsible for the defect in C3H/HeJ mice is identified and data are provided showing that there is a null muation in this gene in another LPS-nonresponsive mouse strain, C56BL/10ScCr.
14. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, FiInlay BB, Wright SD Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med. 176:1992;1665-1671.
15. Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS Lipopolysaccharide (LPS) activation of human endothelial and epithelial cells is mediated by LPS binding protein and soluble CD14. Proc Natl Acad Sci USA. 90:1993;2744-2748.
16. Beamer LJ, Carroll SF, Eisenberg D Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science. 276:1997;1861-1864.
17. Tobias PS, Mathison JC, Ulevitch RJ A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. J Biol Chem. 263:1988;13479-13481.
18. Lamping N, Hoess A, Yu B, Park TC, Kirschning C-J, Pfeil D, Reuter D, Wright SD, Herrmann F, Schumann RR Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. J Immunol. 157:1996;4648-4656.
19. Tobias PS, Soldau K, Iovine NM, Elsbach P, Weiss J Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS. J Biol Chem. 272:1997;18682-18685.
20. Wurfel MM, Wright SD Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid. J Immunol. 158:1997;3925-3934. This provides evidence that LBP and soluble CD14 have a function of lipid-transfer proteins.
21. Wang PY, Kitchens RL, Munford RS Phosphatidylinositides bind to plasma membrane CD14 and can prevent monocyte activation by bacterial lipopolysaccharide. J Biol Chem. 273:1998;24309-24313. The authors show that phosphoinositides bind to CD14 and occupy a site that is either very close to, or identical to, that which binds LPS.
22. Flegel WA, Wolpl A, Mannel DN, Northoff H Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins. Infect Immun. 57:1989;2237-2245.
23. Jack RS, Fan X, Bernheiden M, Rune G, Ehlers M, Weber A, Kirsch G, Mentel R, Furll B, Freudenberg Met al. Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection. Nature. 389:1997;742-745.
24. Wurfel MM, Monks BG, Ingalls RR, Dedrick RL, Delude R, Zhou D, Lamping N, Schumann RR, Thieringer R, Fenton MJet al. Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J Exp Med. 186:1997;2051-2056.
25. Haziot A, Ferrero E, Lin XY, Stewart CL, Goyert SM CD14-deficient mice are exquisitely insensitive to the effects of LPS. Levin J, Alving CR, Munford RS, Redl H Bacterial Endotoxins: Lipopolysaccharides from Genes to Therapy. 1995;349-351 Wiley-Liss Inc, New York.
26. Grunwald U, Fan X, Jack RS, Workalemahu G, Kallies A, Stelter F, Schutt C Monocytes can phagocytose gram-negative bacteria by a CD14-dependent mechanism. J Immunol. 157:1996;4119-4125.
27. Schiff DE, Kline L, Soldau K, Lee J-D, Pugin J, Tobias PS, Ulevitch RJ Phagocytosis of Gram-negative bacteria by a unique CD14-dependent mechanism. J Leukoc Biol. 62:1997;786-794.
28. Gutierrez-Ramos JC, Bluethmann H Molecules and mechanisms operating in septic shock: lessions from knockout mice. Immunol Today. 8:1997;329-334.
29. Warren HS Strategies for the treatment of sepsis. New Engl J Med. 336:1997;952-953.
30. Deitch EA Animal models of sepsis and shock: a review and lessons learned. Shock. 9:1998;1-11. This is a critical evaluation of the strengths and weaknesses of animal models used to study endotoxin-mediated and septic shock.
31. Zanetti G, Baumgartner JD, Glauser MP Sepsis and septic shock. Schweiz Med Wochenschr. 127:1997;489-499.
32. Schimke J, Mathison J, Morgiewicz J, Ulevitch RJ Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc Natl Acad Sci USA. 95:1998;13875-13880. This paper reports the first demonstration that the blockade of LPS binding to CD14 in an animal model provides a therapeutic window for treatment of endotoxic shock. Treatment may begin after initial exposure to LPS and still have a marked therapeutic benefit.
33. Chaudhary PM, Ferguson C, Nguyen V, Nguyen O, Massa HF, Eby M, Jasmin A, Trask BJ, Hood L, Nelson PS Cloning and characterization of two Toll/Interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a multigene receptor family in humans. Blood. 91:1998;4020-4027. The authors report on the cloning of members of the human Toll-like-receptor family.
34. Chan VW, Mecklenbrauker I, Su I, Texido G, Leitges M, Carsetti R, Lowell CA, Rajewsky K, Miyake K, Tarakhovsky A The molecular mechanism of B cell activation by toll-like receptor protein RP-105. J Exp Med. 188:1998;93-101. This describes the intracellular signalling pathways used by a Toll-like-receptor, RP-105.
35. Muzio M, Natoli G, Saccani S, Levrero M, Mantovani A The human toll signaling pathway: divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med. 187:1998;2097-2101. Data presented here suggest that signalling through human Toll-like-receptor 4 diverges upstream of TRAF6 insofar as activation of NF-κB and the stress pathways is concerned.
36. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang H, Goddard A, Wood WI, Gurney AL, Godowski PJ Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature. 17:1998;284-288. The authors provide evidence that human toll-like-receptor 2 is involved in CD14-dependent responses to LPS. The involvement of signalling pathways used by IL-1 is also established.
37. Kirschning CJ, Wesche H, Ayres TM, Rothe M Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med. 188:1998;2091-2097. This report links human toll-like-receptor 2 to CD14-dependent signalling initiated by LPS. Direct evidence supports the contention that LPS-mediated stimulation of human Toll-like-receptor 2 initiates an IL-1R-like NF-κB signalling cascade.